Status:
UNKNOWN
Sex-related Differences in Outcome After Hybrid Coronary Revascularization
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Hybrid coronary revascularization (HCR) has emerged as a favorable technique over traditional coronary artery bypass grafting (CABG) in a select group of patients with multivessel coronary artery dise...
Detailed Description
Hybrid coronary revascularization (HCR) has emerged as a favorable technique over traditional coronary artery bypass grafting (CABG) in a select group of patients with multivessel coronary artery dise...
Eligibility Criteria
Inclusion
- Patients with coronary artery disease and indication to cardiac surgery
Exclusion
- Contraindications to cardiac surgery
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06023355
Start Date
January 1 2024
End Date
December 31 2024
Last Update
November 29 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.